Fabio Paganini, president of US Commercial Business for Boehringer Ingelheim, described the status as a validation of the company's core philosophy that healthier animals foster stronger community connections. By joining this cohort, the company commits to expanding the reach of science-backed education that helps veterinary professionals improve client communication and patient rapport.
In section Releases
Boehringer Ingelheim Earns Human-Animal Bond Certification
Boehringer Ingelheim has been named a Human-Animal Bond Certified Company, a designation announced at the American Veterinary Medical Association Convention in Anaheim. The certification recognizes the firm’s investment in research and educational initiatives designed to strengthen the clinical understanding of the health benefits shared between humans and their companion animals.
The certification program, developed by the North American Veterinary Community (NAVC) and the Human Animal Bond Research Institute (HABRI), consists of a 7.5-hour continuing education course. Since its 2018 launch, over 1,280 veterinary professionals have completed the training, which is hosted on the VetFolio digital platform. Beyond internal training, Boehringer Ingelheim’s support aims to lower barriers for individual clinics seeking to implement these human-animal bond standards into their daily practice.
Comments (0)
No comments yet. Be the first!